BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 12383357)

  • 21. Endothelial cell activation after subarachnoid hemorrhage.
    Frijns CJ; Rinkel GJ; Castigliego D; Van Gijn J; Sixma JJ; Fijnheer R
    Neurosurgery; 2002 Jun; 50(6):1223-9; discussion 1229-30. PubMed ID: 12015839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma endothelin concentrations after aneurysmal subarachnoid hemorrhage.
    Juvela S
    J Neurosurg; 2000 Mar; 92(3):390-400. PubMed ID: 10701524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soluble endoglin and transforming growth factor-β₁ and the development of vasospasm after spontaneous subarachnoid hemorrhage: a pilot study.
    Dietmann A; Lackner P; Fischer M; Broessner G; Pfausler B; Helbok R; Schmutzhard E; Beer R
    Cerebrovasc Dis; 2012; 33(1):16-22. PubMed ID: 22133666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum Glucose and Potassium Ratio as Risk Factors for Cerebral Vasospasm after Aneurysmal Subarachnoid Hemorrhage.
    Matano F; Fujiki Y; Mizunari T; Koketsu K; Tamaki T; Murai Y; Yokota H; Morita A
    J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):1951-1957. PubMed ID: 31060790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Role of ABO Blood Group in Cerebral Vasospasm, Associated Intracranial Hemorrhage, and Delayed Cerebral Ischemia in 470 Patients with Subarachnoid Hemorrhage.
    Dubinski D; Won SY; Konczalla J; Mersmann J; Geisen C; Herrmann E; Seifert V; Senft C
    World Neurosurg; 2017 Jan; 97():532-537. PubMed ID: 27777156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-vasospastic Effects of Epidermal Growth Factor Receptor Inhibitors After Subarachnoid Hemorrhage in Mice.
    Nakano F; Kawakita F; Liu L; Nakatsuka Y; Nishikawa H; Okada T; Kanamaru H; Pak S; Shiba M; Suzuki H
    Mol Neurobiol; 2019 Jul; 56(7):4730-4740. PubMed ID: 30382533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vasospasm probability index: a combination of transcranial doppler velocities, cerebral blood flow, and clinical risk factors to predict cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
    Gonzalez NR; Boscardin WJ; Glenn T; Vinuela F; Martin NA
    J Neurosurg; 2007 Dec; 107(6):1101-12. PubMed ID: 18077946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relation of thrombogenesis in systemic hypertension to angiogenesis and endothelial damage/dysfunction (a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial [ASCOT]).
    Felmeden DC; Spencer CG; Chung NA; Belgore FM; Blann AD; Beevers DG; Lip GY
    Am J Cardiol; 2003 Aug; 92(4):400-5. PubMed ID: 12914869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma vascular endothelial growth factor, soluble VEGF receptor FLT-1, and von Willebrand factor in glaucoma.
    Lip PL; Felmeden DC; Blann AD; Matheou N; Thakur S; Cunliffe IA; Lip GY
    Br J Ophthalmol; 2002 Nov; 86(11):1299-302. PubMed ID: 12386093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
    Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
    J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The predictive value of serum myeloperoxidase for vasospasm in patients with aneurysmal subarachnoid hemorrhage.
    Lim M; Bower RS; Wang Y; Sims L; Bower MR; Camara-Quintana J; Li G; Cheshier S; Harsh GR; Steinberg GK; Guccione S
    Neurosurg Rev; 2012 Jul; 35(3):413-9; discussion 419. PubMed ID: 22370810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased Plasma Galectin-3 Preceding the Development of Delayed Cerebral Infarction and Eventual Poor Outcome in Non-Severe Aneurysmal Subarachnoid Hemorrhage.
    Nishikawa H; Nakatsuka Y; Shiba M; Kawakita F; Fujimoto M; Suzuki H;
    Transl Stroke Res; 2018 Apr; 9(2):110-119. PubMed ID: 28831694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Upregulation of tissue inhibitor of metalloproteinase-1 contributes to restoration of the extracellular matrix in the rabbit basilar artery during cerebral vasospasm after subarachnoid hemorrhage.
    Kurogi R; Kikkawa Y; Matsuo S; Nakamizo A; Mizoguchi M; Sasaki T
    Brain Res; 2015 Aug; 1616():26-36. PubMed ID: 25940763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of cerebral vasopasm after subarachnoid hemorrhage reduced by statin therapy: A multivariate analysis of an institutional experience.
    McGirt MJ; Blessing R; Alexander MJ; Nimjee SM; Woodworth GF; Friedman AH; Graffagnino C; Laskowitz DT; Lynch JR
    J Neurosurg; 2006 Nov; 105(5):671-4. PubMed ID: 17121126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Possible Role of Raf-1 Kinase in the Development of Cerebral Vasospasm and Early Brain Injury After Experimental Subarachnoid Hemorrhage in Rats.
    Zhang J; Xu X; Zhou D; Li H; You W; Wang Z; Chen G
    Mol Neurobiol; 2015 Dec; 52(3):1527-1539. PubMed ID: 25367879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Matrix metalloproteinases, tissue inhibitors of matrix metalloproteinases and angiogenic cytokines in peripheral blood of patients with thyroid cancer.
    Komorowski J; Pasieka Z; Jankiewicz-Wika J; Stepień H
    Thyroid; 2002 Aug; 12(8):655-62. PubMed ID: 12225633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelial damage and angiogenesis in hypertensive patients: relationship to cardiovascular risk factors and risk factor management.
    Felmeden DC; Spencer CG; Belgore FM; Blann AD; Beevers DG; Lip GY
    Am J Hypertens; 2003 Jan; 16(1):11-20. PubMed ID: 12517677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of cilostazol on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a multicenter prospective, randomized, open-label blinded end point trial.
    Senbokuya N; Kinouchi H; Kanemaru K; Ohashi Y; Fukamachi A; Yagi S; Shimizu T; Furuya K; Uchida M; Takeuchi N; Nakano S; Koizumi H; Kobayashi C; Fukasawa I; Takahashi T; Kuroda K; Nishiyama Y; Yoshioka H; Horikoshi T
    J Neurosurg; 2013 Jan; 118(1):121-30. PubMed ID: 23039152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of cerebral vasospasm in patients presenting with aneurysmal subarachnoid hemorrhage: a review.
    Harrod CG; Bendok BR; Batjer HH
    Neurosurgery; 2005 Apr; 56(4):633-54; discussion 633-54. PubMed ID: 15792502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebral Vasospasm and Delayed Cerebral Ischemia after Warfarin-Induced Subarachnoid Hemorrhage.
    Ricarte IF; Calente FG; Alves MM; Gomes DL; Valiente RA; Carvalho FA; Silva GS
    J Stroke Cerebrovasc Dis; 2015 Sep; 24(9):e275-8. PubMed ID: 26198372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.